Annual Revenue:
$89.15M+$89.12M(+297063.33%)Summary
- As of today, SPRY annual revenue is $89.15 million, with the most recent change of +$89.12 million (+297063.33%) on December 31, 2024.
- During the last 3 years, SPRY annual revenue has risen by +$83.64 million (+1519.12%).
- SPRY annual revenue is now at all-time high.
Performance
SPRY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$32.50M+$16.78M(+106.79%)Summary
- As of today, SPRY quarterly revenue is $32.50 million, with the most recent change of +$16.78 million (+106.79%) on September 30, 2025.
- Over the past year, SPRY quarterly revenue has increased by +$30.43 million (+1471.62%).
- SPRY quarterly revenue is now -62.46% below its all-time high of $86.58 million, reached on December 31, 2024.
Performance
SPRY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$142.77M+$30.43M(+27.09%)Summary
- As of today, SPRY TTM revenue is $142.77 million, with the most recent change of +$30.43 million (+27.09%) on September 30, 2025.
- Over the past year, SPRY TTM revenue has increased by +$140.20 million (+5459.66%).
- SPRY TTM revenue is now at all-time high.
Performance
SPRY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SPRY Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10000.0% | +1471.6% | +5459.7% |
| 3Y3 Years | +1519.1% | +10000.0% | +10000.0% |
| 5Y5 Years | +100.0% | +100.0% | +100.0% |
SPRY Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | -62.5% | >+9999.0% | at high | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | -62.5% | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -62.5% | >+9999.0% | at high | >+9999.0% |
SPRY Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $32.50M(+106.8%) | $142.77M(+27.1%) |
| Jun 2025 | - | $15.72M(+97.1%) | $112.34M(+15.7%) |
| Mar 2025 | - | $7.97M(-90.8%) | $97.12M(+8.9%) |
| Dec 2024 | $89.15M(>+9900.0%) | $86.58M(+4086.7%) | $89.15M(+3371.5%) |
| Sep 2024 | - | $2.07M(+313.6%) | $2.57M(+413.6%) |
| Jun 2024 | - | $500.00K(>+9900.0%) | $500.00K(+4900.0%) |
| Mar 2024 | - | $0.00(0.0%) | $10.00K(-66.7%) |
| Dec 2023 | $30.00K(-97.7%) | $0.00(0.0%) | $30.00K(0.0%) |
| Sep 2023 | - | $0.00(-100.0%) | $30.00K(-86.3%) |
| Jun 2023 | - | $10.00K(-50.0%) | $219.00K(-67.5%) |
| Mar 2023 | - | $20.00K(-89.4%) | $673.00K(-48.9%) |
| Dec 2022 | $1.32M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $189.00K(-59.3%) | $1.32M(+16.8%) |
| Jun 2022 | - | $464.00K(-30.0%) | $1.13M(+70.0%) |
| Mar 2022 | - | $663.00K(>+9900.0%) | $663.00K(>+9900.0%) |
| Dec 2021 | $5.51M(>+9900.0%) | - | - |
| Dec 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual revenue?
- What is the all-time high annual revenue for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM revenue?
- What is the all-time high TTM revenue for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is ARS Pharmaceuticals, Inc. annual revenue?
The current annual revenue of SPRY is $89.15M
What is the all-time high annual revenue for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual revenue is $89.15M
What is ARS Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, SPRY annual revenue has changed by +$89.12M (+297063.33%)
What is ARS Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of SPRY is $32.50M
What is the all-time high quarterly revenue for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly revenue is $86.58M
What is ARS Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, SPRY quarterly revenue has changed by +$30.43M (+1471.62%)
What is ARS Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of SPRY is $142.77M
What is the all-time high TTM revenue for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM revenue is $142.77M
What is ARS Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, SPRY TTM revenue has changed by +$140.20M (+5459.66%)